Levels of dimethylarginines and cytokines in mild and severe preeclampsia

Acta Obstetricia et Gynecologica Scandinavica

Volumn 80, Issue 7, 2001, Pages 602-608

  Ellis, J ^a   Wennerholm, U B ^a   Bengtsson, A ^a   Lilja, H ^a   Pettersson, A ^a   Sultan, B ^a   Wennergren, M ^a   Hagberg, H ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Asymmetric dimethylarginine; Cytokines; Dimethylarginines; Preeclampsia; Symmetric dimethylarginine

Indexed keywords

CREATININE; CYTOKINE; INTERLEUKIN 10; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 8; N(G),N(G) DIMETHYLARGININE; NITRIC OXIDE SYNTHASE INHIBITOR; TUMOR NECROSIS FACTOR ALPHA; URIC ACID;

ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MAJOR CLINICAL STUDY; PREECLAMPSIA; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

ARGININE; BLOOD PRESSURE; CYTOKINES; FEMALE; GESTATIONAL AGE; HUMANS; NITRIC OXIDE SYNTHASE; PRE-ECLAMPSIA; PREGNANCY; STATISTICS, NONPARAMETRIC; URIC ACID;

EID: 0034940976     PISSN: 00016349     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0412.2001.800703.x     Document Type: Article

References (37)

1. Placental cytokines and the pathogenesis of preeclampsia
2. Preeclampsia: An excessive maternal inflammatory response to pregnancy
3. Interleukin-6, tumor necrosis factor and soluble tumor necrosis factor receptors in women with preeclampsia
4. Elevated Il-6 in midtrimester amniotic fluid is involved with the onset of preeclampsia
5. Increased serum concentration of interleukin-2 in women who later developed severe preeclampsia
6. Tumor necrosis factor-α is elevated in plasma and amniotic fluid of patients with severe preeclampsia
7. Increased concentrations of cytokines interleukin-6 and interleukin-1 receptor antagonist in plasma of women with preeclampsia: A mechanism for endothelial dysfunction?
8. Expression pattern of cytokines in the different compartments of the feto-maternal unit under various conditions
9. Circulating levels of immunoreactive cytokines in women with preeclampsia
10. Endothelial cell activation by tumour necrosis factor-alpha (TNF-α) and the development of preeclampsia
11. Interleukin-1, interleukin-6 and tumor necrosis factor at delivery in preeclamptic disorders
12. Interleukin-4, interleukin-10 and granulocyte-macrophage colony stimulating factor in second-trimester serum from women with preeclampsia
13. Soluble tumor necrosis factor receptors and interleukin-6 levels in patients with severe preeclampsia
14. Inhibition of NO synthesis in rats during pregnancy produces signs similar to those of preeclampsia
15. The role of NO in the pathogenesis of preeclampsia
16. Effect of asymmetric dimethyl arginine on nitric oxide synthase activity in normal and preeclamptic placentae
17. Evaluation of nitric oxide as a mediator of severe preeclampsia
18. Distinct factors in plasma of preeclamptic women increase endothelial nitric oxide or prostacyclin
19. L-arginine reverses adverse pregnancy changes induced by nitric oxide synthesis inhibition in the rat
20. Cyclic guanosine 3′,5′ monophosphate concentrations in preeclampsia: Effects of hydralazine
21. Plasma concentrations of asymmetric dimethylarginine, a natural inhibitor of nitric oxide synthase, in normal pregnancy and preeclampsia
22. Increased circulating concentrations of asymmetric dimethylarginine (ADMA), an endogenous inhibitor of nitric oxide synthesis, in preeclampsia
23. The L-arginine-nitric oxide pathway
24. Metabolism of methylarginines by human vasculature; implications for the regulation of nitric oxide synthesis
25. Accumulation of endogenous inhibitors for nitric oxide synthesis and decreased content of L-arginine in regenerated endothelial cells
26. Interference of L-arginine analogues with L-arginine transport mediated by the y+ carrier hCAT-2B
27. Nitric oxide synthase inhibitors and hypertension in children and adults
28. Concentration of dimethyl-L-arginine in the plasma of patients with end-stage renal failure
29. Serum levels of NG, NG,-dimethyl-L-arginine, a potential endogenous nitric oxide inhibitor in dialysis patients
30. Guanidino compounds in serum and urine of non-dialyzed patients with chronic renal insufficiency
31. Platelet adhesion to human vascular endothelium is modulated by constitutive and cytokine induced nitric oxide
32. Inflammatory mediators induce the production of nitric oxide in vascular smooth muscle
33. Primary cultures of rat islet capillary endothelial cells
34. Interleukin-8 inhibits the induction of nitric oxide synthase in rat peritoneal neutrophils
35. Differential regulation of cytokine production by nitric oxide
36. Determination of dimethylated arginines in human plasma by high-performance liquid chromatography
37. Tumor necrosis factor, interleukin-1 and interleukin-6 in normal human pregnancy